Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 18 stocks, with a combined market cap of $2,893.14 billion, total revenue of $603.35 billion and a weighted average PE ratio of 33.59.

Market Cap

2,893.14B

Revenue

603.35B

Profits

86.13B

PE Ratio

33.59

Profit Margin

14.28%

Dividend Yield

2.09%

18 Stocks

No.	Symbol	Company Name	Market Cap	% Change	Volume	Revenue
1	LLY	Eli Lilly and Company	720.12B	-0.30%	1,730,531	35.93B
2	JNJ	Johnson & Johnson	363.94B	0.87%	4,167,178	81.80B
3	MRK	Merck & Co., Inc.	327.47B	-0.59%	7,053,004	61.40B
4	ABBV	AbbVie Inc.	284.80B	0.33%	2,226,360	54.40B
5	AZN	AstraZeneca PLC	240.07B	0.32%	2,205,906	47.61B
6	NVS	Novartis AG	200.07B	0.16%	1,088,008	49.92B
7	AMGN	Amgen Inc.	165.46B	-0.55%	1,558,235	29.53B
8	PFE	Pfizer Inc.	161.16B	1.54%	38,376,740	55.09B
9	SNY	Sanofi	117.43B	1.89%	1,218,908	51.60B
10	GSK	GSK plc	92.10B	0.22%	2,353,403	39.41B
11	BMY	Bristol-Myers Squibb Company	91.34B	0.27%	11,804,621	45.53B
12	GILD	Gilead Sciences, Inc.	84.14B	2.40%	5,684,961	27.45B
13	BIIB	Biogen Inc.	32.81B	1.73%	1,246,254	9.66B
14	GRFS	Grifols, S.A.	6.31B	4.14%	2,739,298	7.32B
15	OGN	Organon & Co.	5.39B	2.55%	1,900,348	6.35B
16	AMRN	Amarin Corporation plc	377.88M	7.92%	1,024,671	277.46M
17	SCLX	Scilex Holding Company	133.77M	7.98%	500,291	47.05M
18	MIRA	MIRA Pharmaceuticals, Inc.	10.60M	-1.70%	34,707	-